Activation of the Canonical WNT Signaling Pathway Promotes Ovarian Surface Epithelial Proliferation Without Inducing β-Catenin/Tcf-Mediated Reporter Expression

Developmental Dynamics

Volumn 242, Issue 3, 2013, Pages 291-300

  Usongo, Macalister ^a   Li, Xinfang ^a   Farookhi, Riaz ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

catenin Tcf signaling; LacZ; Ovarian cancer cell lines; Ovarian surface epithelium; Wnts

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; T CELL FACTOR PROTEIN; UVOMORULIN; WNT3A PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; DOWN REGULATION; MOUSE; NONHUMAN; OVARIAN SURFACE EPITHELIUM; OVARY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; WNT SIGNALING PATHWAY;

ANIMALS; ANTIMANIC AGENTS; BETA CATENIN; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; MICE; MICE, TRANSGENIC; OVARY; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

MUS MUSCULUS;

EID: 84874193405     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.23919     Document Type: Article

References (58)

1. Behrens J, Lustig B. 2004. The Wnt connection to tumorigenesis. Int J Dev Biol 48:477-487.
2. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642.
3. Bernard P, Fleming A, Lacombe A, Harley VR, Vilain E. 2008. Wnt4 inhibits beta-catenin/TCF signalling by redirecting beta-catenin to the cell membrane. Biol Cell 100:167-177.
4. Boyer A, Goff AK, Boerboom D. 2010. WNT signaling in ovarian follicle biology and tumorigenesis. Trends Endocrinol Metab 21:25-32.
5. Cadigan KM. 2008. Wnt-beta-catenin signaling. Curr Biol 18:R943-947.
6. Cederroth CR, Pitetti JL, Papaioannou MD, Nef S. 2007. Genetic programs that regulate testicular and ovarian development. Mol Cell Endocrinol 265-266:3-9.
7. Celis JE, Madsen P, Celis A, Nielsen HV, Gesser B. 1987. Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division. Febs Lett 220:1-7.
8. Davies BR, Worsley SD, Ponder BA. 1998. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology 32:69-80.
9. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511.
10. Fagotto F, Funayama N, Gluck U, Gumbiner BM. 1996. Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J Cell Biol 132:1105-1114.
11. Fan HY, O'Connor A, Shitanaka M, Shimada M, Liu Z, Richards JS. 2010. Beta-catenin (CTNNB1) promotes preovulatory follicular development but represses LH-mediated ovulation and luteinization. Mol Endocrinol 24:1529-1542.
12. Gatcliffe TA, Monk BJ, Planutis K, Holcombe RF. 2008. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 18:954-962.
13. Gottardi CJ, Wong E, Gumbiner BM. 2001. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153:1049-1060.
14. Harlow E, Lane D. 1988. Antibodies: a laboratory manual. Cold Spring Habor, NY: Cold Spring Harbor Laboratory Press.
15. Harwood BN, Cross SK, Radford EE, Haac BE, De Vries WN. 2008. Members of the WNT signaling pathways are widely expressed in mouse ovaries, oocytes, and cleavage stage embryos. Dev Dyn 237:1099-1111.
16. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. 1997. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185:82-91.
17. Hsieh M, Johnson MA, Greenberg NM, Richards JS. 2002. Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. Endocrinology 143:898-908.
18. Hsieh M, Mulders SM, Friis RR, Dharmarajan A, Richards JS. 2003. Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: evidence for selective up-regulation in luteinized granulosa cells. Endocrinology 144:4597-4606.
19. Hsieh M, Boerboom D, Shimada M, Lo Y, Parlow AF, Luhmann UFO, Berger W, Richards JS. 2005. Mice null for Frizzled4 (Fzd4(-/-)) are infertile and exhibit impaired corpora lutea formation and function. Biol Reprod 73:1135-1146.
20. Iglesias DM, Hueber PA, Chu L, Campbell R, Patenaude AM, Dziarmaga AJ, Quinlan J, Mohamed O, Dufort D, Goodyer PR. 2007. Canonical WNT signaling during kidney development. Am J Physiol Renal Physiol 293:F494-500.
21. Katoh M, Kirikoshi H, Terasaki H, Shiokawa K. 2001. WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT-beta-catenin-TCF signaling pathway. Biochem Biophys Res Commun 289:1093-1098.
22. Kikuchi A. 2000. Regulation of beta-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 268:243-248.
23. Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, Chaboissier MC, Poulat F, Behringer RR, Lovell-Badge R, Capel B. 2006. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187.
24. Kimura T, Nakamura T, Murayama K, Umehara H, Yamano N, Watanabe S, Taketo MM, Nakano T. 2006. The stabilization of beta-catenin leads to impaired primordial germ cell development via aberrant cell cycle progression. Dev Biol 300:545-553.
25. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810.
26. Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC, Barth AM, McCrea PD. 2004. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res 298:369-387.
27. Mao CD, Hoang P, DiCorleto PE. 2001. Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. J Biol Chem 276:26180-26188.
28. McDonald JH. 2009. Handbook of biological statistics, 2nd ed. Baltimore, MD: Sparky House Publishing.
29. Miller JR. 2002. The Wnts. Genome Biol 3:REVIEWS3001.
30. Mohamed OA, Clarke HJ, Dufort D. 2004. beta-catenin signaling marks the prospective site of primitive streak formation in the mouse embryo. Dev Dyn 231:416-424.
31. Nelson WJ, Nusse R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487.
32. Ohteki T, Parsons M, Zakarian A, Jones RG, Nguyen LT, Woodgett JR, Ohashi PS. 2000. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med 192:99-104.
33. Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, Nedorezov T, Cao A, Forabosco A, Schlessinger D. 2007. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16:2795-2804.
34. Parma P, Radi O, Vidal V, Chaboissier MC, Dellambra E, Valentini S, Guerra L, Schedl A, Camerino G. 2006. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 38:1304-1309.
35. Prieve MG, Waterman ML. 1999. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression. Mol Cell Biol 19:4503-4515.
36. Qu Z, Sun D, Young W. 2011. Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3beta-NF-AT signaling. Cell Biosci 1:18.
37. Rao AS, Kremenevskaja N, Resch J, Brabant G. 2005. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol 153:929-938.
38. Rask K, Nilsson A, Brannstrom M, Carlsson P, Hellberg P, Janson PO, Hedin L, Sundfeldt K. 2003. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. Br J Cancer 89:1298-1304.
39. Ricken A, Lochhead P, Kontogiannea M, Farookhi R. 2002. Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs. Endocrinology 143:2741-2749.
40. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. 1996. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023-1026.
41. Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S. 1998. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 3:659-670.
42. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J. 1997. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 8:1349-1358.
43. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527.
44. Stambolic V, Ruel L, Woodgett JR. 1996. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664-1668.
45. Takeichi M, Nakagawa S. 2001. Cadherin-dependent cell-cell adhesion. Curr Protoc Cell Biol .
46. Tomizuka K, Horikoshi K, Kitada R, Sugawara Y, Iba Y, Kojima A, Yoshitome A, Yamawaki K, Amagai M, Inoue A, Oshima T, Kakitani M. 2008. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet 17:1278-1291.
47. Usongo M, Farookhi R. 2012. beta-catenin/Tcf-signaling appears to establish the murine ovarian surface epithelium (OSE) and remains active in selected postnatal OSE cells. BMC Dev Biol 12:17.
48. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. 1999. Female development in mammals is regulated by Wnt-4 signalling. Nature 397:405-409.
49. Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ. 2002. Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4:963-969.
50. van de Wetering M, Oosterwegel M, Dooijes D, Clevers H. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J 10:123-132.
51. Welshons WV, Engler KS, Taylor JA, Grady LH, Curran EM. 1995. Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. J Cell Physiol 165:134-144.
52. Wheelock MJ, Johnson KR. 2003. Cadherin-mediated cellular signaling. Curr Opin Cell Biol 15:509-514.
53. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
54. Wong GT, Gavin BJ, McMahon AP. 1994. Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol 14:6278-6286.
55. Yao HHC, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, Capel B. 2004. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230:210-215.
56. Yoshioka S, King ML, Ran S, Okuda H, Maclean JA 2nd, McAsey ME, Sugino N, Brard L, Watabe K, Hayashi K. 2012. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/beta-catenin pathway. Mol Cancer Res 10:469-482.
57. Yun MS, Kim SE, Jeon SH, Lee JS, Choi KY. 2005. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118:313-322.
58. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931-940.